Dr. MD Shahjalal | cancer epidemiology | Young Researcher Award

Dr. MD. Shahjalal | cancer epidemiology |Young Researcher Award

Dr. MD Shahjalal, North South University , Bangladesh

Md. Shahjalal is an accomplished public health researcher from Bangladesh ๐Ÿ‡ง๐Ÿ‡ฉ with a strong academic and research background in cancer epidemiology ๐ŸŽ—๏ธ and global health ๐ŸŒ. He holds an MPH in Epidemiology from North South University ๐ŸŽ“ and a BUMS from the University of Dhaka ๐Ÿฅ. Currently serving as Research Coordinator at Research Rats, he has contributed to numerous international publications ๐Ÿ“š, focusing on healthcare economics and cancer care. He is also an academic editor for PLoS ONE ๐Ÿ–‹๏ธ and recipient of national health research grants ๐Ÿ…. His work aims to reduce disparities in cancer outcomes and improve population health ๐Ÿ’ก.

Professional Profile

ORCID

Education & Experienceย 

Md. Shahjalal earned his Master of Public Health (MPH) in Epidemiology ๐Ÿง  from North South University (2018โ€“2019) and Bachelor of Unani Medicine & Surgery (BUMS) ๐Ÿฉบ from the University of Dhaka (2012โ€“2017). His research journey includes roles as Research Assistant (2019โ€“2020), Research Associate (2021โ€“2022), and currently as Research Coordinator at Research Rats Bangladesh (2023โ€“Present) ๐Ÿ”ฌ. He also worked as a Teaching Assistant in Biostatistics at NSU ๐Ÿ“Š. Through these roles, he has developed expertise in grant writing, data analysis, and multi-disciplinary research coordination ๐Ÿค, contributing to impactful studies in cancer and public health.

Professional Developmentย 

Shahjalalโ€™s professional growth is rooted in continuous learning and hands-on research ๐Ÿ“ˆ. From coordinating multi-site cancer studies to assisting in international grant applications ๐Ÿ’ผ, he has gained advanced skills in public health research, data modeling, and scientific writing ๐Ÿ“„. His expertise spans SPSS, STATA, and EXCEL for complex analyses ๐Ÿ“Š. As an academic editor for PLoS ONE ๐Ÿง‘โ€โš–๏ธ, he stays engaged with global research trends. His participation in peer-reviewed publications and collaborative projects reflects his commitment to evidence-based solutions in healthcare. With strong communication and leadership skills ๐Ÿ’ฌ, he thrives in multidisciplinary teams and policy-relevant research environments ๐ŸŒ.

Research Focusย 

Md. Shahjalalโ€™s research primarily targets cancer epidemiology ๐ŸŽ—๏ธ, health-related quality of life, and health economics ๐Ÿ’ฐ. His work evaluates systemic and radiation therapy outcomes, mental health disparities ๐Ÿง , and economic burdens faced by cancer survivors in Bangladesh. He also explores nutritional issues among vulnerable populations ๐Ÿฅฃ and investigates access disparities in cardio-oncology care โค๏ธ. Utilizing statistical modeling and health metrics like EQ-5D-5L, he aims to inform policies for equitable healthcare access ๐Ÿฅ. His contributions support both national and international cancer care reforms ๐ŸŒ, ensuring that scientific insights lead to real-world impact for underserved communities ๐Ÿ“ข.

Awards & Honorsย 

Md. Shahjalal has been recognized for his impactful research through competitive grants and editorial roles ๐Ÿ†. He received the Bangladesh Health Research Grant (2024) as Principal Investigator for a TB-related nutrition project ๐Ÿงช and the General Pharmaceutical Health Research Grant (2023) as Co-Investigator on cardio-oncology care disparities โค๏ธ. With an H-index of 8 on Scopus ๐Ÿ“ˆ, his scholarly influence is growing steadily. He serves as an Academic Editor for PLoS ONE ๐Ÿ–‹๏ธ, a Scopus Q1 journal, reflecting peer recognition of his academic contributions. These honors mark him as a rising leader in public health and medical research ๐ŸŒŸ.

Publication Top Notes

1.๐ŸŽฏ Radioimmunotherapy in Cancer Treatment

Title: Assessing the Clinical Effectiveness of Radioimmunotherapy with Combined Radionuclide/Monoclonal Antibody Conjugates in Cancer Treatment: Insights from Randomised Clinical Trials
Journal: Cancers (2025-04-23)
DOI: 10.3390/cancers17091413
โžค Examines advanced radioimmunotherapy effectiveness using combined agents in cancer trials.

2.๐Ÿ’ฐ Cancer Treatment Costs in Bangladesh

Title: Cancer Driven Direct Medical Costs in Bangladesh: Evidence from Patient Perspective
Journal: Journal of Cancer Policy (2025-03)
DOI: 10.1016/j.jcpo.2025.100565
โžค Highlights patient-incurred medical costs and economic stress related to cancer care.

3.๐Ÿฅ Unplanned Hospitalisation After Cancer Therapy

Title: Emerging Burden of Post-Cancer Therapy Complications on Unplanned Hospitalisation and Costs Among Australian Cancer Patients: A Retrospective Cohort Study Over 14 Years
Journal: Scientific Reports (2025-02-08)
DOI: 10.1038/s41598-025-89247-y
โžค Evaluates long-term health complications and hospital costs post cancer therapy in Australia.

4.๐Ÿฅ— Diet and Dyslipidemia in Type 2 Diabetes

Title: Association between Mediterranean Diet Adherence and Dyslipidemia Among Type-2 Diabetes Mellitus Patients in Dhaka, Bangladesh
Journal: Discover Public Health (2024-10-22)
DOI: 10.1186/s12982-024-00267-x
โžค Investigates the dietary impact on lipid profiles in diabetic patients.5.

5.๐Ÿ’ธ Economic Burden on Cancer Survivors

Title: Economic Burden of Healthcare Services on Cancer Survivors in Bangladesh
Journal: Cancer Reports (2024-08)
DOI: 10.1002/cnr2.2144
โžค Quantifies healthcare costs and financial strain on cancer survivors.

Conclusion

Md. Shahjalal demonstrates exceptional research potential and output in the interdisciplinary field of cancer epidemiology, public health, and health economics. His impactful publications, leadership in funded research, and commitment to health equity mark him as a leading candidate for the Best Researcher Award. His work not only contributes academically but also has tangible implications for national and global health policy.

 

 

 

 

Dr. Nehal Atallah | Pathology | Best Researcher Award

Dr. Nehal Atallah | Pathology | Best Researcher Awardย 

Dr. Nehal Atallah, Nottiigham University hospitals, United Kingdom

Nehal Mohammed Nabil Atallah is a dedicated histopathologist with a strong background in digital pathology, artificial intelligence, cytology, molecular biology, and cancer research. She earned her Bachelor of Medicine and Surgery (MBBCH) with honors from Menoufia University, Egypt, in 2012, followed by a Masterโ€™s degree in Histopathology in 2018. Nehal has extensive experience in pathology education and diagnosis, having served as a Demonstrator and later as an Assistant Lecturer at Menoufia University. Currently, she is pursuing her PhD at the University of Nottingham, focusing on the role of digital pathology and AI in improving breast cancer diagnosis and prognosis. She has actively contributed to the field through research, conference presentations, and memberships in prestigious pathology societies.

Professional Profile:

GOOGLE SCHOLAR

ORCID

SCOPUS

Summary of Suitability for Best Researcher Award

Dr. Nehal Mohammed Nabil Atallah is a highly accomplished researcher in histopathology, digital pathology, and artificial intelligence, with a strong focus on cancer research. Her extensive academic background, including a PhD at the University of Nottingham, multiple prestigious conference presentations, and published research in high-impact journals, highlights her significant contributions to the field. With expertise in molecular diagnostics, bioinformatics, and digital pathology applications, she has made innovative strides in breast cancer prognosis and treatment prediction. Her dedication, research impact, and active engagement in pathology communities make her a strong candidate for the Best Researcher Award.

๐ŸŽ“ Education

  • Bachelor of Medicine and Bachelor of Surgery (MBBCH) โ€“ Faculty of Medicine, Menoufia University, Egypt (Nov 2012) ๐Ÿฅโœจ Graduated with Excellent with Honors
  • Masterโ€™s Degree in Histopathology โ€“ Faculty of Medicine, Menoufia University, Egypt (Nov 2018) ๐Ÿงฌ๐Ÿ”ฌ Thesis: The potential diagnostic role of Trophoblastic Cell Surface Antigen (TROP-2) in papillary thyroid carcinoma
  • PhD in Histopathology โ€“ University of Nottingham & Nottingham University Hospitals NHS Trust, UK (2020 โ€“ Present) ๐ŸŽ“๐Ÿ“Š Focus: Digital Pathology & AI in breast cancer diagnosis & prognosis

๐Ÿ’ผ Work Experience

  • Demonstrator (Teaching Assistant) of Pathology โ€“ Faculty of Medicine, Menoufia University, Egypt (2014โ€“2018) ๐ŸŽ“๐Ÿ“š Taught practical pathology & assisted in specimen diagnosis
  • Assistant Lecturer of Pathology โ€“ Faculty of Medicine, Menoufia University, Egypt (2018โ€“2020) ๐Ÿฅ๐Ÿ” Conducted tutorials, TBL sessions & assisted in diagnoses
  • Full-time PhD Student โ€“ University of Nottingham & Nottingham University Hospitals NHS Trust, UK (2020 โ€“ Present) ๐Ÿค–๐Ÿฉธ Researching AI & Digital Pathology in breast cancer

๐Ÿ† Achievements & Honors

  • Published multiple poster & oral presentations at international pathology & breast cancer conferences ๐Ÿ“œ๐ŸŽค
  • Oral Presentation at the British Division of the International Academy of Pathology & Pathological Society of GB & Ireland (Liverpool 2023) ๐ŸŽ™๏ธ๐Ÿ…
  • Multiple conference contributions at Manchester, Edinburgh, and Nottingham Breast Cancer Conferences ๐Ÿฅ๐Ÿ“ข
  • Abstract submissions to European Breast Cancer Conference & UK pathology conferences ๐Ÿ“๐Ÿ”ฌ

๐ŸŽ–๏ธ Memberships & Professional Affiliations

  • Egyptian Society of Pathologists ๐Ÿ‡ช๐Ÿ‡ฌ
  • Pathological Society of Medicine, UK ๐Ÿ‡ฌ๐Ÿ‡ง
  • Association of Breast Pathology, UK ๐ŸŽ—๏ธ
  • Breast Pathology Research Group, Nottingham University ๐Ÿฅ๐Ÿ”ฌ
  • Nottingham Breast Cancer Research Centre ๐Ÿงฌ๐Ÿ’ก

Publicationย Top Notes:

Prediction of response to anti-HER2 therapy using a multigene assay

 

P026: Prediction of response to anti-HER2 therapy using multigene assay

 

Characterization of Breast Cancer Intra-Tumor Heterogeneity Using Artificial Intelligence

 

Deciphering the Role of ASPM in Breast Cancer: A Comprehensive Multicohort Study

 

Gene regulated by oestrogen in breast cancer 1 (GREB1) as a surrogate oestrogen receptor biomarker